145 related articles for article (PubMed ID: 3314066)
1. The failure of infarction and/or nephrectomy in stage IV renal cell cancer to influence survival or metastatic regression.
Flanigan RC
Urol Clin North Am; 1987 Nov; 14(4):757-62. PubMed ID: 3314066
[TBL] [Abstract][Full Text] [Related]
2. Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma.
Belldegrun A; Shvarts O; Figlin RA
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S88-92. PubMed ID: 10685666
[TBL] [Abstract][Full Text] [Related]
3. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
4. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
Pantuck AJ; Belldegrun AS; Figlin RA
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):693s-696s. PubMed ID: 17255295
[TBL] [Abstract][Full Text] [Related]
6. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
7. Surgery of metastatic renal cell carcinoma and use of renal infarction.
Swanson DA; Wallace S
Semin Surg Oncol; 1988; 4(2):124-8. PubMed ID: 3293153
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
Kwan KG; Kapoor A
Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
[TBL] [Abstract][Full Text] [Related]
9. [Renal cell carcinoma--a current review].
Schmid HP; Szabo J
Praxis (Bern 1994); 1997 May; 86(20):837-43. PubMed ID: 9312811
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.
Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz B; Belldegrun AS; Figlin RA
Cancer; 2003 Jun; 97(12):2995-3002. PubMed ID: 12784334
[TBL] [Abstract][Full Text] [Related]
12. Therapy of locally recurrent renal cell carcinoma after nephrectomy.
Tanguay S; Pisters LL; Lawrence DD; Dinney CP
J Urol; 1996 Jan; 155(1):26-9. PubMed ID: 7490850
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients.
Figlin R; Gitlitz B; Franklin J; Dorey F; Moldawer N; Rausch J; deKernion J; Belldegrun A
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S92-7. PubMed ID: 9457402
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
Margulis V; Matin SF; Wood CG
Curr Opin Urol; 2008 Sep; 18(5):474-80. PubMed ID: 18670270
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.
Kuczyk M; Wegener G; Jonas U
Eur Urol; 2005 Aug; 48(2):252-7. PubMed ID: 15936136
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience.
Franklin JR; Figlin R; Rauch J; Gitlitz B; Belldegrun A
Semin Urol Oncol; 1996 Nov; 14(4):230-6. PubMed ID: 8946623
[TBL] [Abstract][Full Text] [Related]
17. [Long-term results of endovascular treatment of metastatic renal cell cancer].
Granov AM; Gorelov AI; Shumskiĭ IA; Polikarpov AA; Shkol'nik MI; Vorob'ev MI; Karelin MI
Vestn Rentgenol Radiol; 1999; (6):20-3. PubMed ID: 10714226
[TBL] [Abstract][Full Text] [Related]
18. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
Wood CG
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):697s-702s. PubMed ID: 17255296
[TBL] [Abstract][Full Text] [Related]
19. Indications for and results of nephrectomy for metastatic renal cell carcinoma.
Middleton AW
Urol Clin North Am; 1980 Oct; 7(3):711-7. PubMed ID: 6161461
[TBL] [Abstract][Full Text] [Related]
20. [Outcome of patients in metastatic renal cell carcinoma with or without embolization].
Masuda F; Nakada J; Takasaka S; Hishinuma H
Hinyokika Kiyo; 1987 Sep; 33(9):1354-6. PubMed ID: 3434491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
